Abstract
The ability of the brain to recover following neurological insult is of considerable interest in mild traumatic brain injury (mTBI) populations. To date, a limited amount of research has examined changes in brain function over time following mTBI. Investigating whether non-invasive brain stimulation (NIBS) can modulate neurophysiology and cognitive performance is particularly relevant for therapeutic targeting post injury. The purpose of the current study was to investigate the neurobiological effects of a single session of intermittent theta burst stimulation (iTBS) applied to the dorsolateral prefrontal cortex (DLPFC) in participants with mTBI during recovery. Changes to neurophysiology were assessed with electroencephalography (EEG) and transcranial magnetic stimulation combined with EEG (TMS-EEG). Digit span working memory accuracy was assessed as a marker of cognitive performance. 30 patients in the subacute phase following mTBI (within one month post-injury) and 26 demographically matched controls were assessed. Participants also completed 3-month (mTBI: N = 21, control: N = 26) and 6-month (mTBI: N = 15, control: N = 24) follow up sessions. Cluster-based analyses demonstrated iTBS did not reliably modulate neurophysiological activity, and no differences were found in cognitive performance in either mTBI or control group participants across any of the assessment time points. The factors that may have contributed to our results are unclear, and possible limitations to our experimental design are discussed. Our findings highlight additional research is required to establish the effects of iTBS on plasticity and cognition in a mTBI population prior to therapeutic application.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ACTRN12616001038482
Funding Statement
This work was supported by an Australian Postgraduate Award Scholarship (HC) and a National Health and Medical Research Council Fellowship (1135558) (KH).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee of both Alfred Health and Monash University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We do not have ethical approval to make this data publicly available, as our approval predated our inclusion of such approvals (which we now do routinely).
